Skip to main content

Advertisement

SpringerLink
Log in

Diagnostic Evaluation of Urinary Angiogenin (ANG) and Clusterin (CLU) as Biomarker for Bladder Cancer

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Bladder carcinoma is an important worldwide health problem. Both cystoscopy and urine cytology used in detecting bladder cancer suffer from drawbacks where cystoscopy is an invasive method and urine cytology shows low sensitivity in low grade tumors. This study validates easier and less time-consuming techniques to evaluate the value of combined use of angiogenin and clusterin in comparison and combination with voided urine cytology in the detection of bladder cancer patients. This study includes malignant (bladder cancer patients, n = 50), benign (n = 20) and healthy (n = 20) groups. The studied groups were subjected to cystoscopic examination, detection of bilharzial antibodies, urine cytology, and estimation of urinary angiogenin and clusterin by ELISA. The overall sensitivity and specificity were 66 and 75 % for angiogenin, 70 and 82.5 % for clusterin and 46 and 80 % for voided urine cytology. Combined sensitivity of voided urine cytology with the two studied biomarkers was 88 % which is higher than the combined sensitivity of both markers alone (82 %) and that of the cytology with each marker (76 and 80 %) for angiogenin and clusterin respectively. In conclusion, combined use of the cytology with the studied biomarkers can improve the sensitivity for detecting bladder cancer, and may be very useful in monitoring the effectiveness of antiangiogenic and apoptotic therapies in bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig 2
Fig 3
Fig 4

Similar content being viewed by others

References

  1. American Cancer Society (2013) Cancer facts and figures 2013. American Cancer Society, Atlanta

    Google Scholar 

  2. Zaghloul S (2012) Bladder cancer and schistosomiasis. J Egypt Natl Cancer Inst 24:151–159

    Article  Google Scholar 

  3. Eissa S, Shabayek M, Ismail M, Abd-Elateef A (2010) Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase-2 in patients with bladder cancer. IUBMB Life 62(5):394–399

    PubMed  CAS  Google Scholar 

  4. Urquidi V, Goodison S, Kim J, Chang M, Dai Y, Rosser CJ (2012) Vascular enothelail growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection. Urology 79(5):1185.e1–1185.e6

    Article  Google Scholar 

  5. Mitra A (2010) Urine cytologic analysis: special techniques for bladder cancer detection. In: Connection. 169–177

  6. Yafi A, Brimo F, Auger M, Aprikian A, Tanguay S, Kassouf W (2013) Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer. Urol Oncol Semin Orig Investig 32(1):27.e1–6.

    Google Scholar 

  7. Budman L, Kassouf W, Steinberg JR (2008) Biomarkers for detection and surveillance of bladder cancer. Can Urol Assoc J 2:212–221

    PubMed  PubMed Central  Google Scholar 

  8. Li S, Hu G (2010) Angiogenin-mediated rRNA transcription in cancer and neurodegeneration. Int J Biochem Mol Biol 1(1):26–35

    PubMed  PubMed Central  Google Scholar 

  9. Eissa S, Swellam M, Labib RA, El-Zayat T, El Ahmady O (2009) A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot. J Urol 181(3):1353–1360

    Article  PubMed  CAS  Google Scholar 

  10. Hazzaa M, Elashry M, Afifi K (2010) Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder. Pathol Oncol Res 16(1):101–109

    Article  PubMed  CAS  Google Scholar 

  11. Miyake H, Hara I, Gleave M, Eto H (2004) Protection of androgen dependent human prostate cancer cells from oxidative stressinduced DNA damage by overexpression of clusterin and its modulation by androgen. Prostate 61:318–323

    Article  PubMed  CAS  Google Scholar 

  12. American Joint Committee on Cancer (2010) AJCC cancer staging manual. Urinary bladder, 7th edn. Springer, New York, pp 497–502

    Book  Google Scholar 

  13. Felix AS, Soliman AS, Khaled H, Zaghloul MS, Banerjee M, El-Baradie M (2008) The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control 19(4):421–429

    Article  PubMed  Google Scholar 

  14. Zheng YL, Amr S, Saleh DA, Dash C, Ezzat S, Mikhail NN, Gouda I, Loay I, Hifnawy T, Abdel-Hamid M, Khaled H, Wolpert B, Abdel-Aziz MA, Loffredo CA (2012) Urinary bladder cancer risk factors in Egypt: a multicenter case–control study. Cancer Epidemiol Biomark Prev 21(3):537–546

    Article  Google Scholar 

  15. Salem HK, Mahfouz S (2012) Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade. Urology 79(2):379–383

    Article  PubMed  Google Scholar 

  16. Ahmedin J, Ram CT, Taylor M, Asma G, Alicia S, Elizabeth W, Eric JF, Michael JT (2004) American Cancer Society. Bladder Cancer J Clin 96:54–56

    Google Scholar 

  17. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63(2):234–241

    Article  PubMed  Google Scholar 

  18. Gho YS et al (2002) Antiplasmin activity of a peptide that binds to the receptor-binding site of angiogenin. J Biol Chem 277(12):9690–9694

    Article  PubMed  CAS  Google Scholar 

  19. Yang Y, Sun M, Wang L, Jiao B (2013) HIFs, angiogenesis, and cancer. J Cell Biochem 114:967–974

    Article  PubMed  CAS  Google Scholar 

  20. Wong P, Ulyanova T, Organisciak D, Bennett S, Lakins J, Arnold JM, Kutty RK, Tenniswood M, vanVeen T, Darrow RM, Chader G (2001) Expression of multiple forms of clusterin during light-induced retinal degeneration. Curr Eye Res 23:157–165

    Article  PubMed  CAS  Google Scholar 

  21. Trougakso I, So A, Jansen B, Gleave ME, Gonos ES (2004) Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res 64:1834–1842

    Article  Google Scholar 

  22. Leskov K, Klokov D, Li J, Boothman DA (2003) Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem 278:11590–11600

    Article  PubMed  CAS  Google Scholar 

  23. Stejskal D, Fiala R (2006) Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer. Neoplasma 53(4):343–346

    PubMed  CAS  Google Scholar 

  24. Kim N, Yoo J, Han J (2012) Human nuclear clusterin mediates apoptosis by interacting with bcl-xl through c-terminal coiled coil domain. J Cell Physiol 227:1157–1167

    Article  PubMed  CAS  Google Scholar 

  25. Krüger S, Mahnken A, Kausch I, Feller AC (2006) Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma. Urology 67(1):105–109

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Faculty of Pharmaceutical Sciences and Pharmaceutical Technologies, Future University, Cairo, Egypt

    Marwa I. Shabayek & Heba A. Awida

  2. Department of Biochemistry, Faculty of Pharmacy, Azhar University, Cairo, Egypt

    Ola M. Sayed & Hanan A. Attaia

  3. Urology Department, Faculty of Medicine, Azhar University, Cairo, Egypt

    Hamdy Abozeed

Authors
  1. Marwa I. Shabayek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ola M. Sayed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hanan A. Attaia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heba A. Awida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hamdy Abozeed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marwa I. Shabayek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shabayek, M.I., Sayed, O.M., Attaia, H.A. et al. Diagnostic Evaluation of Urinary Angiogenin (ANG) and Clusterin (CLU) as Biomarker for Bladder Cancer. Pathol. Oncol. Res. 20, 859–866 (2014). https://doi.org/10.1007/s12253-014-9765-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-014-9765-y

Keywords

Search

Navigation